Merckle GmbH Pharmathen International S.A. PLIVA Croatia Ltd. Teva Pharmaceuticals Europe B.V.
PolandAll drugs from this manufacturer
-
The medicine is used to treat acromegaly (a disease caused by excess growth hormone), to relieve symptoms associated with neuroendocrine intestinal tumors, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 10 mg ATC: H01CB02
-
The medicine is used to treat acromegaly (a disease caused by excess growth hormone), to inhibit the growth of neuroendocrine tumors in the intestine, and to treat pituitary tumors that secrete excessive amounts of TSH hormone. It also helps to relieve symptoms associated with excessive hormone secretion by the stomach, intestines, and pancreas.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 20 mg ATC: H01CB02
-
The medicine is used to treat acromegaly (a disease related to excess growth hormone), to inhibit the growth of neuroendocrine tumors in the intestine, and to treat pituitary tumors that secrete excessive amounts of TSH hormone.
Dosage form: powder and solvent for preparation of suspension for injection with prolonged release
Active substance Dosage octreotide 30 mg ATC: H01CB02